logo
AAT Bioquest

Cytochrome P450 1B1 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
alpha-NaphthoflavoneIC5050.0 [1]
alpha-NaphthoflavoneKi16.0 [1]
QuercetinIC5077.0 [1], 1000.0 [2], 2200.0 [3]
QuercetinKi23.0 [1]
AcacetinIC507.0 [1], 12.0 [2], 14.0 [3]
AcacetinKi7.0 [1]
2,3',4,5'-TetramethoxystilbeneIC502.0 [1], 6.0 [2], 300.0 [3]
ChrysinIC5024.0 [1], 280.0 [2]
ChrysinKi16.0 [1]
(E)-1-(6-Methoxynaphthalen-2-yl)-3-pyridin-3-ylprop-2-en-1-oneIC504.0 [1], 8.0 [2], 9.0 [3], 65.0 [4]
(E)-3-Naphthalen-2-yl-1-pyridin-3-ylprop-2-en-1-oneIC504.0 [1], 10.0 [2], 53.0 [3], 64.0 [4]
ResveratrolIC5055000.0 [1]
ResveratrolKi800.0 [1], 11200.0 [2]
ApigeninIC5025.0 [1], 360.0 [2]
ApigeninKi64.0 [1]
LuteolinIC5079.0 [1], 360.0 [2]
LuteolinKi56.0 [1]
PterostilbeneIC501400.0 [1]
PterostilbeneKi900.0 [1], 910.0 [2]
DiosmetinIC5029.0 [1]
DiosmetinKi16.0 [1]
HomoeriodictyolIC50240.0 [1], 1716.0 [2]
3-Methoxy-4',5-dihydroxy-trans-stilbeneIC502100.0 [1]
3-Methoxy-4',5-dihydroxy-trans-stilbeneKi900.0 [1]
(E)-5-(4-Methoxystyryl)benzene-1,3-diolIC50800.0 [1]
(E)-5-(4-Methoxystyryl)benzene-1,3-diolKi2060.0 [1], 2100.0 [2]
(S)-7-Hydroxy-2-(4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl)-8-(3-methylbut-2-en-1-yl)chroman-4-oneIC5015000.0 [1], 20000.0 [2]
2-(4-Bromophenyl)-3,4-Dihydroquinazolin-4-OneIC503.0 [1], 25.0 [2], 60.0 [3]
2-(3-Hydroxy-4-methoxyphenyl)quinazoline-4(3H)-oneIC5054.0 [1], 100.0 [2], 151.0 [3]
1-Methoxy-3-[(E)-2-(4-methylsulfanylphenyl)ethenyl]benzeneIC50500.0 [1]
1-Methoxy-3-[(E)-2-(4-methylsulfanylphenyl)ethenyl]benzeneKi30.0 [1], 500.0 [2]
1-Methoxy-2-[(E)-2-(4-methylsulfanylphenyl)ethenyl]benzeneIC50300.0 [1]
1-Methoxy-2-[(E)-2-(4-methylsulfanylphenyl)ethenyl]benzeneKi41.0 [1], 300.0 [2]
1-(4-Pyridyl)-3-(3,4,5-trimethoxyphenyl)-2-propen-1-oneIC505210.0 [1], 6120.0 [2], 8180.0 [3]
2-(3-Methoxy-4-hydroxyphenyl)quinazoline-4(3H)-oneIC5031.0 [1], 141.0 [2], 3100.0 [3]
2-(4-Prop-2-ynoxyphenyl)-3H-quinazolin-4-oneIC502.0 [1], 32.0 [2], 70.0 [3]
2-[4-[(2,4-Difluorophenyl)methoxy]phenyl]-3H-quinazolin-4-oneIC50120.0 [1], 268.0 [2]
2-[4-(2,4-Dichlorophenoxy)phenyl]-3H-quinazolin-4-oneIC504.0 [1], 66.0 [2], 149.0 [3]
2-[2-[2-[2-[2-(3-Fluorophenyl)-6,7,10-trimethoxy-4-oxobenzo[h]chromen-3-yl]oxyethoxy]ethoxy]ethoxy]ethyl 2-aminoacetateIC5012.3 [1], 25300.0 [2], 51200.0 [3]
EstradiolIC5050000.0 [1]
EstradiolKi1900.0 [1]
PyreneIC502.0 [1]
KaempferolIC5047.0 [1]
KaempferolKi43.0 [1]
BerberineIC50330.0 [1]
BerberineKi44.0 [1]
MyricetinKi27.0 [1]
IsorhamnetinIC5017.0 [1]
IsorhamnetinKi3.0 [1]
GalanginIC503.0 [1], 25.0 [2]
Pifithrin-alphaIC5020.6 [1]
Pifithrin-alphaKi4.38 [1]
RutaecarpineIC5055.0 [1]
ChrysoeriolIC5019.7 [1], 20.0 [2]
OxyresveratrolIC5034000.0 [1]
IsopimpinellinIC506380.0 [1]
IsopimpinellinKi11000.0 [1]
KaempferideIC506.0 [1], 25.0 [2]
EupatorinKi35.0 [1]
HortiacineIC5084.0 [1]
3-(1-Naphthyl)-1-(4-pyridinyl)-2-propen-1-oneIC50650.0 [1], 750.0 [2]
(E)-3-(2-Chlorophenyl)-1-(1H-pyrrol-2-yl)prop-2-en-1-oneIC50200.0 [1], 250.0 [2]
6-Methoxy-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4(9),5,7,15,17,19-octaen-14-oneIC50110.0 [1]
(8R,9S,13S,14S,17S)-13-Methyl-2-pyridin-4-yl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diolIC5032.0 [1], 240.0 [2]
7,8-DehydrorutaecarpineIC5055.0 [1], 69.0 [2]
3-(2-Methoxyphenyl)-1-(1H-pyrrole-2-yl)-2-propene-1-oneIC50900.0 [1], 1200.0 [2]
4-[3-(4-Methoxyphenyl)acryloyl]pyridineIC507000.0 [1], 8520.0 [2]
(E)-3-(4-Ethoxy-3,5-dimethoxyphenyl)-1-pyridin-4-ylprop-2-en-1-oneIC50610.0 [1], 698.0 [2]
(E)-3-(3,5-Dimethoxyphenyl)-1-pyridin-4-ylprop-2-en-1-oneIC5031.0 [1], 41.0 [2]
(E)-1-(1H-Pyrrol-2-yl)-3-[4-(trifluoromethoxy)phenyl]prop-2-en-1-oneIC5020000.0 [1]
(E)-3-(3-Ethoxy-4,5-dimethoxyphenyl)-1-pyridin-4-ylprop-2-en-1-oneIC503810.0 [1], 4760.0 [2]
(E)-3-(3,4-Diethoxy-5-methoxyphenyl)-1-pyridin-4-ylprop-2-en-1-oneIC502920.0 [1], 3070.0 [2]
(E)-1-Pyridin-4-yl-3-(3,4,5-triethoxyphenyl)prop-2-en-1-oneIC508620.0 [1], 9920.0 [2]
(E)-3-(1,3-Benzodioxol-5-yl)-1-pyridin-4-ylprop-2-en-1-oneIC502110.0 [1], 3520.0 [2]
(E)-3-(3-Methoxyphenyl)-1-pyridin-4-ylprop-2-en-1-oneIC5054.0 [1], 60.0 [2]
(E)-3-(2-Methoxyphenyl)-1-pyridin-4-ylprop-2-en-1-oneIC5048.0 [1], 60.0 [2]
(E)-1-Pyridin-4-yl-3-(2,3,4-trimethoxyphenyl)prop-2-en-1-oneIC5022.0 [1], 32.0 [2]
(E)-3-(3,4-Dimethoxyphenyl)-1-pyridin-4-ylprop-2-en-1-oneIC50170.0 [1], 230.0 [2]
1-[(E)-2-(2,6-Dimethoxyphenyl)ethenyl]-2,4-dimethoxybenzeneIC501.77 [1], 350.0 [2]
2',3,4,4'-Tetramethoxy-trans-stilbeneIC50190.0 [1], 210.0 [2]
TestosteroneKi411800.0 [1]
MelatoninKi14000.0 [1]
FluoxetineIC50475000.0 [1]
ErythromycinIC5040000.0 [1]
EstroneIC5050000.0 [1]
4-Aminobenzoic acidIC50120000.0 [1]
NaringeninIC503656.0 [1]
AlizarinKi500.0 [1]
BaicaleinKi260.0 [1]
FlavoneIC50600.0 [1]
2-MethoxyestradiolKi36000.0 [1]
3-HydroxyflavoneIC5090.0 [1]
PlumbaginIC506150.0 [1]
HesperetinIC50511.0 [1]
KhellinIC5034600.0 [1]
3,3',4,4',5-PentachlorobiphenylIC5011.0 [1]
FormononetinKi3700.0 [1]
BergaptenIC5015300.0 [1]
Biochanin AKi1900.0 [1]
ImperatorinKi1000.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Cytochrome P450 1B1 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Dec2024https://www.aatbio.com/data-sets/cytochrome-p450-1b1-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024December 21). Quest Database™ Cytochrome P450 1B1 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/cytochrome-p450-1b1-inhibitors-ic50-ki.
BibTeXEndNoteRefMan